ONCOPHAGE Trademark

Trademark Overview

On Wednesday, February 18, 1998, a trademark application was filed for ONCOPHAGE with the United States Patent and Trademark Office. The USPTO has given the ONCOPHAGE trademark a serial number of 75435970. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 5, 2021. This trademark is owned by ANTIGENICS LLC. The ONCOPHAGE trademark is filed in the Pharmaceutical Products category with the following description:

VACCINES FOR THE PREVENTION AND TREATMENT OF CANCER
oncophage

General Information

Serial Number75435970
Word MarkONCOPHAGE
Filing DateWednesday, February 18, 1998
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 5, 2021
Registration Number2280075
Registration DateTuesday, September 21, 1999
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 15, 1998

Trademark Statements

Goods and ServicesVACCINES FOR THE PREVENTION AND TREATMENT OF CANCER

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 5, 2021
Primary Code005
First Use Anywhere DateMonday, May 24, 1999
First Use In Commerce DateMonday, May 24, 1999

Trademark Owner History

Party NameAGENUS INC.
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressLEXINGTON, MA 024217305
Party NameANTIGENICS INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressNew York, NY 10010
Party NameANTIGENICS LLC
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressNew York, NY 10111
Party NameANTIGENICS LLC
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressNew York, NY 10111
Party NameANTIGENICS LLC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNew York, NY 10111

Trademark Events

Event DateEvent Description
Friday, November 5, 2021CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Wednesday, September 5, 2012ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 5, 2012TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 9, 2011AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, September 23, 2009REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, September 23, 2009REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, August 25, 2009ASSIGNED TO PARALEGAL
Friday, August 21, 2009TEAS SECTION 8 & 9 RECEIVED
Friday, September 28, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 28, 2007APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 28, 2007TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 10, 2007CASE FILE IN TICRS
Saturday, September 30, 2006REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, May 8, 2006RESPONSE RECEIVED TO POST REG. ACTION - SEC. 8 & 15
Monday, May 8, 2006PAPER RECEIVED
Tuesday, January 24, 2006POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Saturday, December 31, 2005ASSIGNED TO PARALEGAL
Monday, September 12, 2005REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Monday, September 12, 2005TEAS SECTION 8 & 15 RECEIVED
Tuesday, September 21, 1999REGISTERED-PRINCIPAL REGISTER
Friday, July 16, 1999ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, July 13, 1999ASSIGNED TO EXAMINER
Friday, June 4, 1999STATEMENT OF USE PROCESSING COMPLETE
Friday, June 4, 1999USE AMENDMENT FILED
Tuesday, March 9, 1999NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 15, 1998PUBLISHED FOR OPPOSITION
Friday, November 13, 1998NOTICE OF PUBLICATION
Tuesday, September 29, 1998APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 28, 1998ASSIGNED TO EXAMINER

Related Keywords

oncophage cancer treatment prevention vaccines